RxDoctor Payments DataLook up a doctor →

Charles Davis, PA

Medical · Athens, GANPI 1952397564

Payments from drug & device makers

$16,555in general payments, 2019–2025

Across 817 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Merck$1K
  • GSK$852
  • Johnson & Johnson$826
  • Gilead$808
  • Bristol Myers Squibb$694
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis73$1,505
Merck54$1,197
GSK52$852
Johnson & Johnson(2 entities)45$826
Gilead(2 entities)41$808
Bristol Myers Squibb32$694
Incyte Corporation27$639
Pharmacyclics LLC, An Abbvie Company32$593
Daiichi Sankyo Inc.27$578
Pfizer39$562
Bayer19$522
Sanofi21$443
Eisai Inc.21$418
Jazz Pharmaceuticals Inc.15$408
Takeda Pharmaceuticals U.S.A., Inc.16$397
Seagen Inc.24$392
Exelixis Inc.23$372
AbbVie13$367
AstraZeneca(2 entities)16$367
Genentech USA, Inc.19$364
Amgen17$312
Astellas Pharma US Inc9$255
Sobi, Inc12$234
Stemline Therapeutics Inc.10$231
Tersera Therapeutics LLC10$224
Adaptive Biotechnologies Corporation9$216
Karyopharm Therapeutics Inc.12$214
Epizyme, Inc.11$201
Rigel Pharmaceuticals, Inc.9$173
Blueprint Medicines Corporation8$166
Regeneron Healthcare Solutions, Inc.7$143
Beigene USA, Inc.6$129
AVEO Pharmaceuticals, Inc.6$123
Sumitomo Pharma America, Inc.6$121
Ipsen Biopharmaceuticals, Inc5$109
Sanofi-aventis U.S. LLC1$99
Puma Biotechnology, Inc.6$98
ADC Therapeutics America, Inc.5$94
Beone Medicines USA, Inc.5$93
EMD Serono, Inc.5$86
Lilly USA, LLC4$75
Boehringer Ingelheim3$62
E.r. Squibb & Sons, L.L.C.4$60
Morphosys, US Inc.3$57
Acrotech Biopharma Inc.3$51
G1 Therapeutics, Inc.3$50
Deciphera Pharmaceuticals Inc.3$49
Pharmaessentia USA Corporation2$43
Taiho Oncology, Inc.1$35
Apellis Pharmaceuticals, Inc.2$32
Geron Corporation1$27
Cycle Pharmaceuticals Inc1$26
Janssen Scientific Affairs, LLC1$26
Sun Pharmaceutical Industries Inc.1$25
Dendreon Pharmaceuticals LLC1$24
Mirati Therapeutics, Inc.1$21
Immunocore Limited1$21
Spectrum Pharmaceuticals Inc.1$21
Avyxa Pharma, LLC1$20
Syndax Pharmaceuticals, Inc.1$20

How this compares

$16,555 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia →

Medicare billing

Part B allowed, 2024
$118,002
Medicare patients
68
Services billed
4,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Athens

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →